These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 12373863)

  • 1. [The role of lipid metabolism in Alzheimer's disease].
    Kamino K; Tanaka T; Kida T; Ohkochi M; Tanii H; Kudo T; Takeda M
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2002 Aug; 22(4):103-10. PubMed ID: 12373863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cholesterol and Alzheimer's disease].
    Kálmán J; Janka Z
    Orv Hetil; 2005 Sep; 146(37):1903-11. PubMed ID: 16255374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Genetic risk factors for Alzheimer's disease].
    Tooyama I; Matsuo A; Yasuhara O
    Nihon Rinsho; 2004 Jan; 62 Suppl():46-51. PubMed ID: 15011318
    [No Abstract]   [Full Text] [Related]  

  • 4. Transport pathways for clearance of human Alzheimer's amyloid beta-peptide and apolipoproteins E and J in the mouse central nervous system.
    Bell RD; Sagare AP; Friedman AE; Bedi GS; Holtzman DM; Deane R; Zlokovic BV
    J Cereb Blood Flow Metab; 2007 May; 27(5):909-18. PubMed ID: 17077814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Apolipoprotein E4 and late-onset Alzheimer's disease].
    Tamaoka A
    Nihon Rinsho; 1994 Dec; 52(12):3257-65. PubMed ID: 7853720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein E polymorphism and susceptibility to Alzheimer's disease.
    Kamboh MI
    Hum Biol; 1995 Apr; 67(2):195-215. PubMed ID: 7729825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New approach for the studies on Alzheimer's disease: a beta 1-42 and acetylcholine].
    Hoshi M
    Seikagaku; 1997 Mar; 69(3):181-7. PubMed ID: 9125900
    [No Abstract]   [Full Text] [Related]  

  • 8. Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy.
    Bu G
    Nat Rev Neurosci; 2009 May; 10(5):333-44. PubMed ID: 19339974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aging, gender and APOE isotype modulate metabolism of Alzheimer's Abeta peptides and F-isoprostanes in the absence of detectable amyloid deposits.
    Yao J; Petanceska SS; Montine TJ; Holtzman DM; Schmidt SD; Parker CA; Callahan MJ; Lipinski WJ; Bisgaier CL; Turner BA; Nixon RA; Martins RN; Ouimet C; Smith JD; Davies P; Laska E; Ehrlich ME; Walker LC; Mathews PM; Gandy S
    J Neurochem; 2004 Aug; 90(4):1011-8. PubMed ID: 15287908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro.
    Wisniewski T; Castaño EM; Golabek A; Vogel T; Frangione B
    Am J Pathol; 1994 Nov; 145(5):1030-5. PubMed ID: 7977635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pathological cross talk between apolipoprotein E and amyloid-beta peptide in Alzheimer's disease: emerging gene-based therapeutic approaches.
    Iurescia S; Fioretti D; Mangialasche F; Rinaldi M
    J Alzheimers Dis; 2010; 21(1):35-48. PubMed ID: 20182014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alzheimer disease: mercury as pathogenetic factor and apolipoprotein E as a moderator.
    Mutter J; Naumann J; Sadaghiani C; Schneider R; Walach H
    Neuro Endocrinol Lett; 2004 Oct; 25(5):331-9. PubMed ID: 15580166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deficiency in mitochondrial aldehyde dehydrogenase increases the risk for late-onset Alzheimer's disease in the Japanese population.
    Kamino K; Nagasaka K; Imagawa M; Yamamoto H; Yoneda H; Ueki A; Kitamura S; Namekata K; Miki T; Ohta S
    Biochem Biophys Res Commun; 2000 Jun; 273(1):192-6. PubMed ID: 10873585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.
    Chen Z; Zhong C
    Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein E receptors: linking brain development and Alzheimer's disease.
    Herz J; Beffert U
    Nat Rev Neurosci; 2000 Oct; 1(1):51-8. PubMed ID: 11252768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain lipid metabolism, apolipoprotein E and the pathophysiology of Alzheimer's disease.
    Bales KR
    Neuropharmacology; 2010; 59(4-5):295-302. PubMed ID: 20079752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The magnitude of brain lipid peroxidation correlates with the extent of degeneration but not with density of neuritic plaques or neurofibrillary tangles or with APOE genotype in Alzheimer's disease patients.
    Montine TJ; Markesbery WR; Zackert W; Sanchez SC; Roberts LJ; Morrow JD
    Am J Pathol; 1999 Sep; 155(3):863-8. PubMed ID: 10487843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diminished neuronal metabolic activity in Alzheimer's disease. Review article.
    Salehi A; Swaab DF
    J Neural Transm (Vienna); 1999; 106(9-10):955-86. PubMed ID: 10599878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Astrocyte lipoproteins, effects of apoE on neuronal function, and role of apoE in amyloid-beta deposition in vivo.
    Fagan AM; Holtzman DM
    Microsc Res Tech; 2000 Aug; 50(4):297-304. PubMed ID: 10936884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Greasing the wheels of Abeta clearance in Alzheimer's disease: the role of lipids and apolipoprotein E.
    Fan J; Donkin J; Wellington C
    Biofactors; 2009; 35(3):239-48. PubMed ID: 19472365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.